3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Breast Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Localized, Operable Non-small Cell Lung Cancer
1
Liver Neoplasms
1
Liver Diseases
1
Interventions
Sirolimus
4
Everolimus
3
Anticonvulsants
2
ziprasidone
1
perampanel
1
enzalutamide
1
clevidipine
1
brivaracetam
1
Zolpidem
1
Warfarin
1
Vigabatrin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Therapeutic Touch
1
Temozolomide
1
Surgical Procedures, Operative
1
Sulfasalazine
1
Spironolactone
1
Sevoflurane
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Registries
1
Radiotherapy
1
Propofol
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Epilepsy
×
Neuropsychological Tests
×
Clear all
NCT02320136
2023-12-01
HFO
University of Zurich
Unknown
120 enrolled